X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-21 | IDXX | Idexx Laboratories Inc /De | Szostak M Anne | Dir | S - Sale+OE | $512.97 | -2,306 | 2,063 | -53% | -$1,182,917 | |||||
| M | 2022-09-23 | EBF | Ennis, Inc. | Quiroz Alejandro | Dir | S - Sale | $20.45 | -21,580 | 11,117 | -66% | -$441,406 | |||||
| D | 2025-05-09 | EBF | Ennis, Inc. | Burnett Vera | CFO, Treasurer | P - Purchase | $19.09 | +498 | 28,020 | +2% | +$9,506 | |||||
| M | 2025-05-02 | EBF | Ennis, Inc. | Schaefer Michael J | Dir | S - Sale | $17.91 | -3,148 | 29,599 | -10% | -$56,384 | |||||
| M | 2025-04-29 | EBF | Ennis, Inc. | Schaefer Michael J | Dir | S - Sale | $17.85 | -11,987 | 32,747 | -27% | -$213,989 | |||||
| M | 2025-04-25 | EBF | Ennis, Inc. | Schaefer Michael J | Dir | S - Sale | $18.00 | -14,865 | 44,734 | -25% | -$267,524 | |||||
2025-02-07 | IDXX | Idexx Laboratories Inc /de | Szostak M Anne | Dir | S - Sale | $465.95 | -3,000 | 3,061 | -49% | -$1,397,835 | ||||||
2024-09-06 | IDXX | Idexx Laboratories Inc /de | Szostak M Anne | Dir | S - Sale | $469.37 | -500 | 6,061 | -8% | -$234,686 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |